Gapping up
News:
- AAN +4.9% (to be acquired by IQVentures for $10.10 per share)
- COYA +3.9% (files for 603,136 share common stock offering by selling shareholder)
- BWAY +3.9% (announces broad market entry into Canada for its Deep TMS system)
- MRNS +2.7% (announces topline results from the Phase 3 double-blind, randomized, placebo-controlled RAISE trial)
- CG +1.7% (looking into selling its electric power producer Cogentrix for as much as $3.0-4.0 bln, according to FT.com)
- IRON +1.6% (files for 4,944,000 shares of common stock at a price of $36.00/share)
- GLPG +1.2% (presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024)
- BLCO +1.1% (announces presentation of new data at the European Dry Eye Society 2024 Congress)
- OVID +1% (reports on Takeda's (TAK) announcement of phase 3 topline study results for Soticlestat)
- NFBK +0.8% (approves $10 mln share repurchase authorization)
- REGN +0.8% (reports updated Linvoseltamab data showcasing continued deepening of responses in patients with heavily pre-treated multiple myeloma)